Pharma CEO Pair Become China’s Richest Couple
Following Hansoh’s recent IPO in Hong Kong, CEO Zhong Huijuan and husband Sun Piaoyang, CEO of Jiangsu Hengrui, are now officially the wealthiest couple in China. Sun, a former high…
Address: Ocean Towers 15th Floor, 550 Yanan East Road, Shanghai ,China
Tel: +86 21 5306 0001
Web: http://www.zuelligpharma.com/
Zuellig Pharma was first established in Asia over 60 years ago and has become the leading healthcare distribution solution specialist in 15 countries and regions in Asia. Zuellig Pharma combines regional market expertise with constantly evolving quality services, IT systems, facilities and management in order to create enduring market partnerships based on trust, open communication, responsiveness, vision and top results.
In the past six decades, Zuellig Pharma has built up extensive experience in Asia Pacific, meeting the ever-changing needs of the market place through continuous innovation, efficiency and forward looking management. By combining extensive local market expertise with global vision and the latest technological developments Zuellig Pharma provides dedicated, cutting-edge distribution solutions to the healthcare industry. Zuellig Pharma’s state-of-the art facilities operate in strict accordance with rigorous quality management standards and set industry benchmarks for excellence.
Distribution services
Following Hansoh’s recent IPO in Hong Kong, CEO Zhong Huijuan and husband Sun Piaoyang, CEO of Jiangsu Hengrui, are now officially the wealthiest couple in China. Sun, a former high…
Dr Jinzi Jason Wu of Ascletis – a Chinese biotech success story that has developed rapidly in recent years – outlines the company’s journey from its founding in 2013 to…
PD-1 inhibitors have boosted survival rates for many cancer patients since their introduction in the US five years ago. Last year, MSD and BMS began selling these expensive therapies in…
More accessible and affordable healthcare for all: China’s government has outlined several proposals to expand healthcare reform in a report released 4th June by the General Office of the State…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports to developed nations, are increasingly forging closer links. With US trade tariffs affecting both…
The company sold 551 million shares in the latest IPO on the Hong Kong Exchange and plans to invest half of its earnings in R&D. Hong Kong is now the…
With Hong Kong now established as the world’s second largest funding hub for biotech, at this week’s BIO 2019 conference in Philadelphia, the HKEX’s Michael Chan outlined some of the…
China is a hot topic in Big Pharma investor updates these days. The world’s second-largest pharmaceutical market boasts sales growth that continuously surpasses that of the US and other developed…
Hong Kong is now the world’s second largest funding hub for biotech according to Hong Kong Chief Executive Carrie Lam. During her speech at the 2nd HKEx Biotech Summit on…
On May 30th, and with much fanfare, Pfizer Upjohn officially inaugurated its global headquarters in the heart of Shanghai, China. Following a global re-organization mid-2018, Pfizer now operates three business…
Carsten Lu of Chinese biotech Adlai Nortye outlines his strategy for navigating a crowded immuno-oncology field in China, his partnership strategy, and the firm’s early move to establish a footprint…
Better known for its panda sanctuary and spicy local cuisine, Chengdu could be the first Chinese city to offer mutual health insurance. Eric Bouteiller examines French firm VYV’s first steps…
See our Cookie Privacy Policy Here
